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Abstract
Background: The Duffy-binding protein II of Plasmodium vivax (PvDBPII) has been considered as an
attractive target for vaccine-mediated immunity despite a possible highly polymorphic nature.
Among seven PvDBP domains, domain II has been shown to exhibit a high rate of nonsynonymous
polymorphism, which has been suggested to be a potential immune (antibody binding) evasion
mechanism. This study aimed to determine the extent of genetic polymorphisms and positive
natural selection at domain II of the PvDBP gene among a sampling of Thai P. vivax isolates.
Methods:  The  PvDBPII  gene was PCR amplified and the patterns of polymorphisms were
characterized from 30 Thai P. vivax isolates using DNA cloning and sequencing. Phylogenetic
analysis of the sequences and positive selection were done using DnaSP ver 4.0 and MEGA ver 4.0
packages.
Results: This study demonstrated a high rate of nonsynonymous polymorphism. Using Sal I as the
reference strain, a total of 30 point-mutations were observed in the PvDBPII gene among the set of
Thai P. vivax isolates, of which 25 nonsynonymous and five synonymous were found. The highest
frequency of polymorphism was found in five variant amino acids (residues D384G, R390H, L424I,
W437R, I503K) with the variant L424I having the highest frequency. The difference between the
rates of nonsynonymous and synonymous mutations estimated by the Nei and Gojobori's method
suggested that PvDBPII antigen appears to be under selective pressure. Phylogenetic analysis of
PvDBPII Thai P. vivax isolates to others found internationally demonstrated six distinct allele groups.
Allele groups 4 and 6 were unique to Thailand.
Conclusion:  Polymorphisms within PvDBPII  indicated that Thai vivax malaria parasites are
genetically diverse. Phylogenetic analysis of DNA sequences using the Neighbour-Joining method
demonstrated that Thai isolates shared distinct alleles with P. vivax isolates from different
geographical areas. The study reported here will be valuable for the development of PvDBPII-based
malaria vaccine.
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Background
Molecular mechanisms of invasion by Plasmodium vivax
merozoites are mediated by the Duffy-binding-like (DBL)
family of homologous erythrocyte binding protein (EBPs)
located within the micronemes of merozoites that recog-
nize specific receptors on red blood cell [1]. PvDBP is a
140-kDa protein belonging to a family of erythrocyte
binding proteins characterized by a functionally con-
served cysteine-rich region. The similarity among DBL
families of EBPs is the greatest within two adjacent
cysteine-rich domains, designated as the amino cysteine-
rich domain (N-cys) and carboxyl cysteine-rich domain
(C-cys) [2]. The amino cysteine-rich domain has been
identified as the principle adhesion region binding to
erythrocyte receptors, while the function of the carboxyl
cysteine-rich domain remains unclear. This amino-
cysteine-rich domain is present within the 330 amino acid
region II, which has been shown to contain the binding
motifs necessary for adherence to the Duffy antigen recep-
tor for chemokines (DARC), required for erythrocyte inva-
sion [3]. Critical binding motifs in PvDBPII have been
mapped to a 170 amino acid spanning region between
cysteines 4 and 7 (amino acids 291–460) [4]. Cysteine
residues are conserved within the identified binding
motif, whereas other amino acids are highly polymorphic,
having a high ratio of nonsynonymous to synonymous
mutations [5].
The polymorphic nature of the PvDBP, particularly its
region II (DBPII) is a major impediment to the develop-
ment of a broadly protective vaccine against vivax malaria.
A study in Papua New Guinea showed 43 and 18 unique
nonsynonymous mutations in 10 Madang [6] and 24
Wosera vivax isolates [7], respectively, whereas 19 unique
nonsynonymous mutations were described in 10 Colom-
bian vivax isolates [8]. Often the mutations were found in
corresponding locations in the protein sequence of iso-
lates from different geographical areas. Amino acids sub-
stitutions at D384G, K386(N/Q), N417K, L424I, W437R,
and I503K were found in both Papua New Guinea isolates
and Colombia isolates [5-8]. Such results demonstrate
that many similar alleles are widely distributed among P.
vivax from different geographical areas. Polymorphic pat-
terns in the PvDBP cluster within the critical erythrocyte-
binding segment imply the existence of a selection pres-
sure on PvDBP [9]. Under the influence of immune pres-
sure, the distribution of existing antigenic polymorphisms
affects the population structure in which newly selected
mutants spread and may provide insight to the evolution
and selection of parasite populations over time [10]. Pol-
ymorphisms of PvDBPII  require further exploration
among vivax isolates from different geographic areas, par-
ticularly south-east Asia where a large proportion of vivax
infections take place. Therefore, the gene polymorphisms
within the region II domain of the P. vivax DBP among
Thai P. vivax isolates were investigated.
Methods
P. vivax samples and DNA preparation
Plasmodium vivax isolates were obtained from malaria
patients with informed consent at the outpatient clinic,
Hospital for Tropical Diseases, Faculty of Tropical Medi-
cine, Mahidol University, Bangkok, from May, 2002 to
June, 2003 under a protocol approval by the Ethics Com-
mittee, Faculty of Tropical Medicine, Mahidol University.
The confirmation of P. vivax infection was done by micro-
scopic examination of the parasites in thick and thin
blood smears. Approximately 1 ml of venous blood was
collected from each individual in 0.5 M ethylene-diamine
tetra-acetic acid (EDTA) tubes and kept at -20°C until use.
Genomic DNA was extracted from 200 μl of blood using
a High Pure PCR Template Preparation Kit (Roche, Man-
nhein, Germany) according to the manufacturer's proto-
col.
Genotyping of P. vivax isolates at the PvDBPII locus
P. vivax DBPII gene was amplified by PCR using the oligo-
nucleotide primers, DBPII-F; 5'-CACCACGATCTCTAGT-
GCTATTATA-3' and DBPII-R; 5'-TGTCACAACTTCCTGAG
TATT-3' [11]. PCR cycling conditions were 94°C for 3
min, 55°C for 1 min, and 72°C for 1 min for 35 cycles fol-
lowed by a 10 min extension at 72°C. PCR products were
stained with 0.1 μg/ml ethidium bromide and visualized
by digital photography under ultraviolet light. The PCR
products were run adjacently to 0.1 μg/lane of a 2-log
DNA ladder (NewEngland BioLabs, Inc. MA, USA) as a
standard DNA marker.
Purification of PCR products, DNA cloning and DNA 
sequencing of PvDBPII gene
PCR products were purified by QIAquick PCR purification
Kit (Qiagen Inc., Valencia, CA) following the manufac-
turer's instructions. The PCR products were cloned
directly into pCR-Blunt II-TOPO cloning vector using a
Zero Blunt TOPO PCR cloning kit (Invitrogen, La Jolla,
CA). For DNA sequencing of the species-specific ampli-
cons, excess dNTPs and unincorporated primers were
eliminated using the QIAquick PCR purification kit (Qia-
gen Inc., Valencia, CA). DNA sequencing was performed
by fluorescence based methodologies using MegaBACE
DNA Analysis Systems (Amersham Biosciences, Piscata-
way, NJ). The sequences have been submitted to the Gen-
Bank under the accession number EF219451, EF368159–
368180, EF379127–379135. Due to the possibility of
multiple genotypes within parasites taken from one indi-
vidual, direct sequencing was not performed. Instead, at
least five clones were sequenced from each corresponding
PCR product and sequences of these had to be identical to
meet our quality control standards.Malaria Journal 2008, 7:112 http://www.malariajournal.com/content/7/1/112
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Analysis of PvDBPII gene sequences
The alignment of complete sequences of 30 PvDBPII genes
was analysed by Sequencher ver 4.2 software (Gene Code
Corporation, Ann Arbor, MI) [12,13]. Sequences were
aligned using CLUSTALX Multiple Sequence Alignment
Program developed by the National Center for Biotech-
nology Information (NCBI, Bethesda, MD). The percent
similarity was assessed using BLASTN (NCBI, Bethesda,
MD) and BioEdit ver 7.0 software (Tom Hall Isis Thera-
peutics, Isis Pharmaceuticals, CA), DnaSP ver 4.0 [14] and
MEGA ver 4.0 Beta program [15].
Analysis of natural selection
Evidence of positive natural selection was determined by
comparing the rate of nonsynonymous and synonymous
substitutions in region II of the P. vivax DBP gene. The
rates of substitutions were estimated using the Nei and
Gojobori's method [16] with the Jukes and Cantor correc-
tion [17,18] as implemented in the MEGA program.
Standard error was determined by 1000 bootstrap replica-
tions. Negative selection acting on most coding genes can
be identified typically when the rate on nonsynonymous
mutations is less than the rate of synonymous mutations
(kn <Ks). However, when positive selection is acting on a
gene, the rate of nonsynonymous mutations will exceed
that of synonymous mutations (kn > Ks). Two other tests
of neutrality were performed by Tajima's D test, Fu and
Li's D- and F-tests on DnaSP 4 software using P. knowlesi
DBP as an outgroup. Tajima's D test compares the estima-
tion of nucleotide diversity calculated in two ways (θ cal-
culated from the number of segregating sites and π
calculated from average pairwise nucleotide diversity) in
order to test for a departure from neutrality. Fu and Li's D
and F test, departures from neutrality are identified as a
deviation between estimates of θ (derived from the
number of mutations in external branches of the phylog-
eny and from the total number of mutations giving the
index D or from the average pairwise diversity π giving the
index F) [19].
Phylogenetic analysis
Phylogenetic analysis was used to investigate the associa-
tions of PvDBPII gene with sequences elucidated from dif-
ferent geographical regions. The gene tree was constructed
using regions common to all available PvDBPII
sequences. Forty five PvDBPII genes sequences found in
GenBank were compiled and compared to Thai isolates
including the sequences from a reference strain, Sal I, one
individual sequence from Vietnam, Indonesia, Brazil and
India as well as 2, 3, 3 and 31 sequences from Bangladesh,
Colombia (COL), South Korea (SK) and Papua New
Guinea (PNG), respectively (Table 1). A phylogenetic tree
was derived from the aligned nucleotide sequences using
the Neighbour-Joining (NJ) method with 1000 bootstrap
replicates, the Tamura's three-parameter distance model
as implemented in the MEGA ver 4.0 Beta program [20].
Results
PCR products and genetic polymorphisms of PvDBPII 
gene among Thai isolates
The PCR amplification of the P. vivax DBPII gene from 30
Thai isolates yielded DNA fragments of approximately
990 base pairs in length (Figure 1). A 900 bp was selected
after excluding primer regions and adjacent bases which
did not give uniformly reliable sequences. DNA analysis
in comparison to the PvDBP gene of Sal I reference strain
revealed amino acid polymorphisms across the entire
domain II of PvDBP protein (300 amino acids) among
Thai isolates. Among the 30 polymorphic sites, 29
showed monomorphic mutation (changed into one
amino acid-type) and only a position 386(N/Q) showed
dimorphic mutation (changed into two amino acid-
types) (Table 2). Among 300 amino acids within PvDBPII,
25 nonsynonymous (representing 83% of all isolates) and
five synonymous mutations were identified (Table 2).
High frequencies of variant amino acids (>50%) were
found and included L424I (86%), D384G (76%), W437R
(63%), R390H (56%), and I503K (56%) residue poly-
morphisms.
Based on the variation of nonsynonymous mutations and
in comparison to Sal I the Thai haplotyes were designated
as TA (TA1-TA25). TA1, TA5 and TA11 haplotypes were
identified in two isolates while TA17 was identified in
three isolates. The other 21 haplotypes were identified in
single isolates (Table 3). The cluster analysis of PvDBPII
Table 1: PvDBPII sequences deposited in GenBank used in the study
species locality GenBank accession number
P. vivax Papua New Guinea AF289480–289653, AF469522–469602, AY970848–970925, AF291096, AF695565, DQ156519
P. vivax Colombia AY341907, DQ156513, AY341899
P. vivax Korea AF215737, AF215738, DQ156523
P. vivax India DQ156514
P. vivax Brazil DQ153520
P. vivax Vietnam DQ156518
P. vivax Indonesia DQ156521
P. vivax Sal I M37514, DQ156512Malaria Journal 2008, 7:112 http://www.malariajournal.com/content/7/1/112
Page 4 of 8
(page number not for citation purposes)
amino acid sequences among 25 haplotypes based on
Neighbour-Joining method was organized into five main
groups (Figure 2).
Evidence of natural selection
To investigate whether natural selection contributed to
generation of this diversity, the ratio of nonsynonymous
(Kn) to synonymous substitutions (Ks) was compared
between Thai and Sal I isolates. The number of nonsynon-
ymous substitutions per nonsynonymous sites (Kn)
(0.00956) exceeded the number of synonymous substitu-
tions per synonymous sites (Ks) (0.00754). The Kn/Ks
ratio was 1.270 predicting that positive selection may be
occurring in region II of DBP favouring the fixation of
amino acid replacement in certain areas of the protein.
The statistic tests detecting departure from neutrality
showed evidence that the observed polymorphism might
be trending natural selection. Tajima's D value was -
0.084549 with P > 0.10. The Fu and Li, D and F values
were -0.92031 with P > 0.10 and -0.7654 with P > 0.10,
respectively.
Phylogenetic tree of PvDBPII
Phylogenetic tree analysis of DNA sequences derived from
region II of the P. vivax DBP constructs based on the
Neighbour-Joining method using Tamura's three-parame-
ter distance is shown in Figure 3. Variation of DNA
sequence was categorized into nine distinct alleles groups.
Thai isolates were widely distributed amongst groups 1, 3,
5 and 7 also containing isolates from different geographi-
cal regions. PvDBPII DNA sequence of Thai isolates was
related to isolates sets from Papua New Guinea and India
(group 1), Korea (group 3), Colombia (group 5) and a
second Papua New Guinea set (group 7). The Sal I refer-
ence strain used in this study was included in group 2
composed of isolates from Colombia, Korea, Bangladesh,
Indonesia, and Vietnam, but bootstrap analysis demon-
strated that the Thai isolates were distinct from this group.
Most isolates from Papua New Guinea formed a distinc-
tive group comprised of 8 and 9.
Discussion
The process invasion into erythrocyte is essential for sur-
vival of P. vivax parasite and requires DBP to bind the
Duffy blood group antigen that act as erythrocyte recep-
tor, Duffy antigen receptor for chemokines (DARC). Plas-
modium vivax utilizes genetic diversity of individual
functional proteins to evade the host immune system and
resist many anti-malarial drugs [21]. In this study, poly-
morphisms and natural selection was assessed and sug-
gested positive natural selection in PvDBPII  of Thai
isolates. Although, non significant could be observed
trending positive selection. As this is only a glimpse at the
Table 2: Amino acid changes found in PvDBPII gene among 30 Thai isolates, comparing to DBP Sal I sequence.
Position of the amino acid   Ќ  
268 276 281 306 308 333 351 367 371 375 378 384 385 386 390
SalI CGT AAC GTT TTT AGG CTT AGT ATC AAA AAT CGC GAT GAA AAG CGT
Thai AGT AAT GTA TTG AGT TTT TGT ACC GAA GAT CGT GGT AAA AAT/CAG CAT
SalI R N V F R L S I K N R D E K R
Thai S N V L S F C T E D R G K N/Q H
a (1/30) (1/30) (1/30) (2/30) (8/30) (14/30) (1/30) (2/30) (6/30) (7/30) (30/30) (23/30) (14/30) (13/30) (17/30)
b 3 3 3 6 26 46 3 6 20 23 100 76 46 43 56
Position of the amino acid     
398 404 417 419 424 433 436 437 447 464 475 486 503 507 513
Sal I TCT ACA AAT ATA TTA CAG AGA TGG TCA ATC CCA CAA ATA AAC ACG
Thai ACT AGA AAA ATG ATA AAG ACA CGG TCC ATA GCA GAA AAA CAC AAG
Sal I S T N I L Q R W S I P Q I N T
Thai T R K M I K T R S I A E K H K
a (3/30) (3/30) (11/30) (1/30) (26/30) (1/30) (1/30) (19/30) (1/30) (1/30) (3/30) (2/30) (17/30) (1/30) (1/30)
b 10 10 36 3 86 3 3 63 3 3 10 6 56 3 3
a Showing the detection frequency of each amino acids variant on PvDBPII protein among 30 Thai isolates.
b Percentage of detection frequency calculated from value in panel "a".
  High prevalence (>50%) of variant amino acids.
Ќ Dimorphic mutation (changed into two amino acid-types)
Schematic diagram of PvDBPII gene showing the location of  the primers Figure 1
Schematic diagram of PvDBPII gene showing the location of 
the primers.
Signal N-cys C-cys TMMalaria Journal 2008, 7:112 http://www.malariajournal.com/content/7/1/112
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overall population, a wide range study including more
subjects from different areas of Thailand would give a
more detailed picture.
Analysis of 300 amino acids of PvDBPII protein relative to
the Sal I reference strain, resulted in 25 nonsynonymous
mutations being found. In addition, 142 nonsynonymous
mutations were reported in 76 Papua New Guinea isolates
[22]. The nonsynonymous mutations in PvDBPII might
have an effect on parasite binding to erythrocyte receptors.
Nonsynonymous mutations often times result in amino
acid substitutions that alter charge and therefore host
immune/antibody recognition [6]. Thus, excessive stable
polymorphism generation within the PvDBPII  ligand
domain from high rate of nonsynonymous polymor-
phisms may promote the parasite escape of host immune
response [9].
The high frequency (>50%) of L424I (86%), D384G
(76%), W437R (63%), R390H (56%), and I503K (56%)
residues were found in Thai isolates relative to Sal I PvDBP
sequence. The finding is in contrast to previous studies
showing R308S (67%), D384G (66%), and S447K (59%)
in Papua New Guinea, D384G (59%) in Colombia and
D384G (85%) in Brazil isolates [23]. Of the following var-
iants N417K, W437R and I503K, all having been shown
to be involved in evasion to antibody neutralization, var-
iant N417K was found in low frequency (36%) while
W437R and I503K were high (63% and 56% respectively)
in Thai isolates. These results were different from what has
been currently reported in that the low frequencies of var-
iants N417K (27.5%) and W437R (27.5%) and the high
Table 3: PvDBPII haplotypes observed among 30 Thai isolates.
Haplotype name Amino acid haplotype* No. of isolate observed (%)
TA 1 RFRFSIKDGKNHSTKIIQRRPQKNT 2(6.6)
TA 2 RFSFSIKDGKNHSTKIIQRRPQKNT 1(3.3)
TA3 RFSFSIKDGKKHSTKIIQRRPQKNT 1(3.3)
TA 4 RFRLSIKDGKNHSTKIIQRRPQKNT 1(3.3)
TA 5 RFRFSIENGKNRSTNIIQRRPQINT 2(6.6)
TA6 RFRFSIENGKNRSTKIIQRRPQINT 1(3.3)
TA 7 RFSFSIKDGKNHSTNIIQRRPQINT 1(3.3)
TA 8 RFRLSIENGEKHSTKIIQRRPQKNT 1(3.3)
TA 9 RFRLSIENGEQRSTKIIQRRPQKNT 1(3.3)
TA 10 RFRLSIENGEKRSTKMIQRRPQINT 1(3.3)
TA 11 RLSLLSIKNGKNHTRNIIQRWPQINT 2(6.6)
TA 12 SFSLSIKNGKNHTRNIQRWPEINT 1(3.3)
TA 13 RFRLSTKNGEKHSTNIIQRWPQKHT 1(3.3)
TA 14 RFRLSTKNGEKHSTNIIQRWPQKHT 1(3.3)
TA 15 RFSLSIKNGEKRSTNIIQRWPQKNT 1(3.3)
TA 16 RFRLSIKNGEKRSTNIIQRWPQINT 1(3.3)
TA 17 RFRFSIKNDEKRSTNIIQRRAQKNT 3(10)
TA 18 RFRLSIKNDEKRSTNIIQRRPQKNT 1(3.3)
TA19 RFRFSIKNDKKRSTNIIQRRPQKNT 1(3.3)
TA 20 RFRLSIKNDKKRSTKIIKTRPQINT 1(3.3)
TA 21 RFRLSIKNDKKRSTNIIQRWPQINT 1(3.3)
TA 22 RFSFSIKDGKNHSTNILQRRPQKNT 1(3.3)
TA23 RFRLSIKNGEKHSTNILQRWPQKNK 1(3.3)
TA 24 RFRLCIKNGEKHSTNILQRWPEINT 1(3.3)
TA 25 RFRLSIKNGEKHSTNILQRWPQINT 1(3.3)
* Amino acid residues included in the haplotypes are as follows: 268, 306, 308, 333, 351, 367, 371, 375, 384, 385, 386, 390, 398, 404, 417, 419, 424, 433, 436, 437, 475, 486, 
503, 507, 513.
Neighbour-Joining tree of PvDBPII amino acid sequence of 25  variants observed among 30 Thai isolates Figure 2
Neighbour-Joining tree of PvDBPII amino acid sequence of 25 
variants observed among 30 Thai isolates. The PvDBPII haplo-
type for each variant could be seen in Table 3.
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Phylogenetic tree of PvDBPII obtaining from Thai P. vivax isolates and other isolates from different geographical malaria endemic  areas, i.e. PNG (Papua New Guinea), India, COL (Colombia), Korea, Bangladesh, Brazil, Indonesia, Vietnam, and Sal I Figure 3
Phylogenetic tree of PvDBPII obtaining from Thai P. vivax isolates and other isolates from different geographical malaria endemic 
areas, i.e. PNG (Papua New Guinea), India, COL (Colombia), Korea, Bangladesh, Brazil, Indonesia, Vietnam, and Sal I. Numbers 
at nodes indicate percentage support of 1000 bootstrap replicates (bootstrap support values below 10 are not presented).
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
!
￿
￿
￿
￿
￿
￿
￿
￿
"
$
&
￿
￿
￿
￿
’
￿
￿
￿
"
$
&
￿
￿
￿
￿
’
￿
￿
’
(
$
)
*
!
￿
￿
￿
￿
￿
￿
￿
￿
+
!
￿
￿
&
!
￿
*
.
/
￿
￿
0
￿
￿
0
￿
￿
+
!
￿
￿
&
!
￿
*
.
/
￿
￿
0
￿
￿
0
￿
￿
+
)
!
1
￿
&
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
$
￿
*
.
￿
!
￿
￿
￿
￿
￿
￿
￿
￿
2
￿
*
￿
￿
!
3
￿
￿
￿
￿
￿
￿
￿
￿
.
!
&
￿
￿
￿
￿
￿
￿
￿
￿
￿
.
￿
4
￿
(
5
6
7
￿
￿
’
0
0
￿
’
￿
￿
(
5
6
7
￿
￿
’
0
0
￿
’
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
0
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
’
￿
￿
￿
￿
￿
’
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
’
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
"
$
&
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
’
’
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
0
0
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
0
￿
￿
￿
￿
￿
￿
’
0
’
￿
’
￿
￿
￿
￿
￿
￿
’
0
’
￿
￿
￿
￿
￿
￿
’
￿
0
￿
￿
￿
￿
￿
￿
￿
￿
’
￿
0
￿
￿
’
￿
￿
￿
￿
￿
’
￿
0
￿
￿
￿
’
￿
￿
￿
￿
’
￿
0
￿
￿
￿
0
￿
￿
￿
￿
￿
￿
’
0
’
￿
￿
￿
￿
￿
￿
￿
￿
’
0
’
￿
￿
￿
￿
￿
￿
’
￿
0
￿
￿
￿
’
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
’
￿
￿
￿
￿
’
￿
0
￿
￿
￿
￿
￿
￿
￿
￿
’
￿
0
￿
￿
￿
￿
￿
￿
￿
￿
’
￿
0
￿
￿
￿
￿
￿
￿
￿
￿
’
￿
0
￿
￿
￿
￿
￿
￿
￿
￿
’
￿
0
￿
￿
’
￿
￿
￿
￿
￿
’
￿
0
￿
￿
￿
￿
￿
￿
￿
￿
’
￿
0
￿
￿
￿
0
￿
￿
￿
￿
’
￿
0
￿
￿
’
￿
￿
￿
￿
￿
’
￿
0
￿
￿
’
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
’
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿
￿

	









8
9
:
;
<
=
>
@
<
A
=
;
<
=
>
:
>
@
>
C
C
8
=
<
;
8
<
;
=
=
>
=
;
=
;
:
:
=
>
>
@
9
=
=
>
:
:
:
;
>
C
9
9
:
=
<
8
=
A
A
<
<
@
<
=
A
@
A
=
=
A
>
C
>
C
>
C
A
<
<
=
>
8
>
A
=
9
A
<
<
=
A
=
A
@
;
9
<
<
8
@
A
=
9
C
A
>
>
CMalaria Journal 2008, 7:112 http://www.malariajournal.com/content/7/1/112
Page 7 of 8
(page number not for citation purposes)
frequency of variant I503K (55%) found in Brazil and low
frequencies of all three variants (N417K, W437R, I503K)
found in either Colombia (47%, 18%, 12%, respectively)
and/or Papua New Guinea (23%, 26%, 29%, respectively)
(Table 4) [23]. N417K, W437R and I503K have recently
been shown to not be directly involved in erythrocyte
binding, but possibly in inhibition of antibody binding to
erythrocyte receptor [24]. Moreover, the variant amino
acid T404R was identified in PvDBPII domains of three
Thai isolates (Table 2) which is similar to the recent data
in Papua New Guinea [22]. Other Thai variants, namely
R308S, K371E, D384G, E385K, N386(N/Q), R390H,
T404R, N417K, L424I, W437R, S447S and I503K, were
also found in isolates of other regions, demonstrating
commonality with a progenitor clone (Table 4). The other
18 polymorphic residues of PvDBPII ligand domain were
recognized only among Thai isolates, indicative of diver-
gence from a progenitor clone.
The study showed that 25 PvDBPII haplotypes clustered
into five main groups (dominant haplotypes) (Table 3)
on the basis of nonsynonymous mutations is similar, but
not entirely the same, with data from Papua New Guinea
isolates whose 27 different PvDBPII haplotypes clustering
into three dominant PvDBPII  haplotypes. Potentially
dominant PvDBPII haplotypes observed in these popula-
tions could be less immunogenic, thereby may help pro-
moting parasite success and escaping the host immune
response [22].
Phylogenetic analysis of PvDBPII suggested that Thai iso-
lates fell into 6 different alleles groups. Among these,
group 1 formed a group with a subset of Papua New
Guinea isolates. Groups 4 and 6 were unique among Thai
P. vivax isolates. However, the rest of the allele groups that
Thai isolates fell into were more related to the isolates
from Korea, India, and Colombia than from Papua New
Guinea (Figure 3). The observations derived from the
PvDBPII phylogeny suggested that single Indian isolate
found in group 1 appeared to share a common ancestor
close to a subset of Thai and Papua New Guinea isolates,
demonstrating common ancestoral origins. Thai and
Papua New Guinea isolate subsets in group 7 also may
have shared common ancestor heritage. Recently, it was
reported that travellers' malaria among foreigners at the
Hospital for Tropical Diseases, Bangkok, Thailand includ-
ing India and Papua New Guinea patients were though to
have acquired their infections in their countries. Malaria
importations from country to country can occur by either
immigration or travel, and changing malaria attack rates
in the countries of exposure are likely to influence the
incidence of imported disease [25]. Additionally, these
results demonstrated that there is some difference in the
nucleotide or amino acid variation in PvDBPII among iso-
lates from Thai, Korea, India, Papua New Guinea and
Colombia, but most importantly, unique variants from
Thailand do exist and should be considered in future vac-
cine development of PvDBPII. It should be noted that the
present highly diverse phylogenetic tree was constructed
relying on polymorphisms within a single gene, demon-
strating the high degree of topological variation that can
be found using this technique, but also highlighting the
problems that can be associated with gene sampling in
phylogenetic studies [26]. Use of a combination of several
genes with different rates of evolutions has been suggested
as an efficient way to overcome this difficulty to prove the
existence of a unique tree relating these sequences [27].
Finally, it must also be pointed out that in many situa-
tions a single-gene phylogeny may be interesting in itself.
Awareness of the problems of orthology (genes in differ-
ent species that derive from a common ancestor) assign-
ment and tree reconstruction artifacts should be
considered.
Conclusion
The results indicated that PvDBPII gene among Thai iso-
lates is genetically diverse. Nonsynonymous polymor-
phism in PvDBPII was the predominant result of which
variant L424I showed the highest frequency (86%). Five
dominant PvDBPII haplotypes could be clustered among
Thai isolates. The high frequency of polymorphisms and
the presence of distinct alleles within PvDBPII  gene
among P. vivax from different geographical areas could
provide complication in malaria vaccine development,
but should be considered important parts of the develop-
ment process.
Table 4: Frequencies of the most common variant amino acids in PvDBPII, comparing to Sal I sequence (accession number M37519)
# R308S D384G K386N K386Q N417K L424I W437R S447K I503K
Thai 26 76 40 3 36 86 63 0 56
C O L * 0 5 9 2 304 7 4 7 1 80 1 2
PNG* 67 66 8 11 23 34 26 59 29
Brazil* 12.5 85 12.5 0 27.5 32.5 27.5 0 55
* The frequencies of the common variant amino acid data were referable according to Sousa et al. 2006.
# The first letter represented the amino acid in that position in Sal I sequences, and the other letter represents the substituted amino acid.
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